Skip to main content
. Author manuscript; available in PMC: 2016 Oct 12.
Published in final edited form as: Transfusion. 2013 Apr 29;53(10 Pt 2):2459–2466. doi: 10.1111/trf.12218

TABLE 4.

Relative analytical sensitivity of NAT systems on (dilutions of) the Eurohep HBV DNA genotype A2 standard, Ultrio HBV NAT–yield samples, and HBsAg-positive and Ultrio initially nonreactive samples as determined by parallel line probit analysis

Panel Sensitivity (CI)
TaqScreen relative to Ultrio Ultrio Plus relative to Ultrio TaqScreen relative to Ultrio Plus
Eurohep standard 4.21 (2.01–9.98) 2.09 (1.21–3.87) 2.01 (1.02–4.23)
HBV NAT yields 2.32 (1.72–3.18) 2.46 (1.97–3.13) 0.94 (0.71–1.26)
HBsAg yields 93.9 (17.8–1135) 43.1 (10.7–350) 1.60 (0.89–3.10)